1. Home
  2. AAPG vs MHO Comparison

AAPG vs MHO Comparison

Compare AAPG & MHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • MHO
  • Stock Information
  • Founded
  • AAPG 2009
  • MHO 1976
  • Country
  • AAPG China
  • MHO United States
  • Employees
  • AAPG N/A
  • MHO N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • MHO Homebuilding
  • Sector
  • AAPG Health Care
  • MHO Consumer Discretionary
  • Exchange
  • AAPG Nasdaq
  • MHO Nasdaq
  • Market Cap
  • AAPG 3.6B
  • MHO 3.4B
  • IPO Year
  • AAPG 2025
  • MHO 1986
  • Fundamental
  • Price
  • AAPG $32.48
  • MHO $124.08
  • Analyst Decision
  • AAPG Strong Buy
  • MHO Strong Buy
  • Analyst Count
  • AAPG 3
  • MHO 2
  • Target Price
  • AAPG $49.00
  • MHO $153.00
  • AVG Volume (30 Days)
  • AAPG 7.7K
  • MHO 234.5K
  • Earning Date
  • AAPG 11-19-2025
  • MHO 10-22-2025
  • Dividend Yield
  • AAPG N/A
  • MHO N/A
  • EPS Growth
  • AAPG N/A
  • MHO N/A
  • EPS
  • AAPG N/A
  • MHO 17.05
  • Revenue
  • AAPG $54,524,554.00
  • MHO $4,475,753,000.00
  • Revenue This Year
  • AAPG N/A
  • MHO N/A
  • Revenue Next Year
  • AAPG $368.64
  • MHO N/A
  • P/E Ratio
  • AAPG N/A
  • MHO $7.31
  • Revenue Growth
  • AAPG N/A
  • MHO 4.77
  • 52 Week Low
  • AAPG $16.50
  • MHO $100.22
  • 52 Week High
  • AAPG $48.45
  • MHO $172.23
  • Technical
  • Relative Strength Index (RSI)
  • AAPG 39.03
  • MHO 36.55
  • Support Level
  • AAPG $30.93
  • MHO $128.83
  • Resistance Level
  • AAPG $34.50
  • MHO $132.39
  • Average True Range (ATR)
  • AAPG 1.00
  • MHO 3.21
  • MACD
  • AAPG 0.17
  • MHO 0.19
  • Stochastic Oscillator
  • AAPG 56.90
  • MHO 16.91

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About MHO M/I Homes Inc.

M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprise a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.

Share on Social Networks: